These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 22516402)
21. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. Togni M; Windecker S; Cocchia R; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM J Am Coll Cardiol; 2005 Jul; 46(2):231-6. PubMed ID: 16022947 [TBL] [Abstract][Full Text] [Related]
22. Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study. Mischie AN; Nazzaro MS; Fiorilli R; De Felice F; Musto C; Confessore P; Parma A; Boschetti C; Violini R Catheter Cardiovasc Interv; 2013 Sep; 82(3):E184-91. PubMed ID: 23359371 [TBL] [Abstract][Full Text] [Related]
24. Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model. Vassilev D; Gil R; Milewski K EuroIntervention; 2011 Sep; 7(5):614-20. PubMed ID: 21930466 [TBL] [Abstract][Full Text] [Related]
25. Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents. Plass CA; Sabdyusheva-Litschauer I; Bernhart A; Samaha E; Petnehazy O; Szentirmai E; Petrási Z; Lamin V; Pavo N; Nyolczas N; Jakab A; Murlasits Z; Bergler-Klein J; Maurer G; Gyöngyösi M JACC Cardiovasc Interv; 2012 Jul; 5(7):741-51. PubMed ID: 22814779 [TBL] [Abstract][Full Text] [Related]
26. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Hamilos M; Sarma J; Ostojic M; Cuisset T; Sarno G; Melikian N; Ntalianis A; Muller O; Barbato E; Beleslin B; Sagic D; De Bruyne B; Bartunek J; Wijns W Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678 [TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340 [TBL] [Abstract][Full Text] [Related]
28. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis. Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735 [TBL] [Abstract][Full Text] [Related]
29. Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation. Ito S; Nakasuka K; Morimoto K; Inomata M; Yoshida T; Tamai N; Suzuki S; Murakami Y; Morino A; Shimizu Y; Sato K J Invasive Cardiol; 2011 Feb; 23(2):57-64. PubMed ID: 21297201 [TBL] [Abstract][Full Text] [Related]
30. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model. Sumida A; Gogas BD; Nagai H; Li J; King SB; Chronos N; Hou D Cardiovasc Revasc Med; 2015 Sep; 16(6):351-7. PubMed ID: 26294337 [TBL] [Abstract][Full Text] [Related]
31. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related]
32. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents. Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J; J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent. Yazdani SK; Vorpahl M; Nakano M; Su SH; Kolodgie FD; Virmani R EuroIntervention; 2011 Nov; 7(7):835-43. PubMed ID: 22082579 [TBL] [Abstract][Full Text] [Related]
34. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Won H; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Int J Cardiovasc Imaging; 2014 Feb; 30(2):263-70. PubMed ID: 24221904 [TBL] [Abstract][Full Text] [Related]
35. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model. Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590 [TBL] [Abstract][Full Text] [Related]
36. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation. Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128 [TBL] [Abstract][Full Text] [Related]
38. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
39. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial. Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE; Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. Hamilos MI; Ostojic M; Beleslin B; Sagic D; Mangovski L; Stojkovic S; Nedeljkovic M; Orlic D; Milosavljevic B; Topic D; Karanovic N; Wijns W; J Am Coll Cardiol; 2008 Jun; 51(22):2123-9. PubMed ID: 18510958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]